Clinical Pearls for Febrile Neutropenia Prevention: An Algorithmic, Case-Based Guide to Navigating the Use of Myeloid Growth Factors

 

Release Date: November 20, 2014

Expiration Date: November 20, 2015

 

Pharmacy Clinical Specialist, Blood and Marrow Transplant

PGY2 Oncology Residency Director

Wake Forest Baptist Medical Center

Winston-Salem, NC

 

Clinical Pharmacogenomics Scientist

Moffitt Cancer Center

DeBartolo Family Personalized Medicine Institute

Tampa, FL

 

This activity has been designed to address the educational needs of clinical, health-system, oncology, and other pharmacists involved in the management of patients at risk for the development of febrile neutropenia. This activity will also benefit other healthcare professionals interested in the management of patients at risk for the development of febrile neutropenia.

 

Upon proper completion of this activity, participants should be better able to:

This activity is jointly provided by the University of North Carolina Eshelman School of Pharmacy and Paradigm Medical Communications, LLC. The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation Statement

This activity, UAN 0046-9999-14-277-H01-P, will provide 1.0 contact hour or 0.1 CEU for viewing this web-based home study activity in its entirety, achieving a score of 70% or higher on the posttest, and completing an activity evaluation.
 

Upon fulfillment of the participation requirements, verification of credit will be maintained with the University of North Carolina Eshelman School of Pharmacy and a record of successful completion of this activity will be submitted to ACPE/National Association of Boards of Pharmacy’s CPE Monitor. Only learners who provide valid NABP e-Profile ID numbers and PIN numbers (month and date of birth) in their registration information within 30 days of submitting for credit will be submitted to ACPE/NABP’s CPE Monitor for official record of credit. Pharmacy learners who do not provide this information will not be eligible to receive credit.

 

This CPE activity is supported by an educational grant from Teva Pharmaceuticals.

 

To receive a statement of completion:

A statement of completion will be available for download/printing immediately following your successful completion of the posttest and evaluation.

 

There is no fee required for participation in this activity.

 

For questions regarding CPE credit, contact Paradigm at (845) 398-5949.

 

In accordance with ACPE requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

 

 

 

Paradigm Medical Communications, LLC staff members have no financial conflicts to disclose.

 

The University of North Carolina Eshelman School of Pharmacy staff members have no financial conflicts to disclose.

Supported Browsers
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

 

Technical Support: If you have any technical problems, please call (845) 398-5942 or email contactus@paradigmmc.com.

 

The University of North Carolina Eshelman School of Pharmacy and Paradigm Medical Communications, LLC have implemented a system to resolve conflicts of interest for each CPE activity to help ensure content is objective, independent, fairly balanced, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CPE content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACPE’s Standards and Guidelines.

 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

 

This CPE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC, and the University of North Carolina Eshelman School of Pharmacy. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

 

The materials provided for this activity are for informational purposes only and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC or the University of North Carolina Eshelman School of Pharmacy. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

 

Paradigm Medical Communications, LLC and the University of North Carolina Eshelman School of Pharmacy are committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

 

This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

 

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CPE activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

 

Paradigm Medical Communications, LLC and the University of North Carolina Eshelman School of Pharmacy do not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC and the University of North Carolina Eshelman School of Pharmacy will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC and the University of North Carolina Eshelman School of Pharmacy staff members review individual test results to the extent necessary to record and track participants’ credits.

 

© 2014 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.

 

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.